Niels Svenstrup
Corporate Officer/Principal presso PEPGEN INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Niels Svenstrup is currently the SVP-Chemistry, Manufacturing & Control at PepGen Inc. Prior to this, he was the Senior Vice President-Development at Cydan II, Inc. from 2017 to 2021.
He was also the Director-CMC at Ascendis Pharma A from 2015 to 2017 and the Head-Medicinal Chemistry Department at H.
Lundbeck A from 2008 to 2015.
Dr. Svenstrup holds a graduate and doctorate degree from the University of Southern Denmark.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PEPGEN INC.
-.--% | 17/05/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Niels Svenstrup
| Società | Posizione | Inizio |
|---|---|---|
| PEPGEN INC. | Corporate Officer/Principal | 01/04/2021 |
Precedenti posizioni note di Niels Svenstrup
| Società | Posizione | Fine |
|---|---|---|
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/04/2021 |
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 01/07/2017 |
| H. LUNDBECK A/S | Corporate Officer/Principal | 01/11/2015 |
Formazione di Niels Svenstrup
| University of Southern Denmark | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PEPGEN INC. | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| Aziende private | 1 |
|---|---|
Cydan II, Inc.
Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Niels Svenstrup
